Fny Investment Advisers, LLC Zynerba Pharmaceuticals, Inc. Call Options Transaction History

Fny Investment Advisers, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2019 Jan 10, 2020	SELL	$5.61 - $8.57 $112 - $171	-20 Closed	0 $0
Q3 2019 Oct 25, 2019	SELL	$7.56 - $15.44 $75 - $154	-10 Reduced 33.33%	20 $0
Q2 2019 Jul 24, 2019	BUY	$5.4 - $15.5 $81 - $232	15 Added 100.0%	30 $0
Q3 2018 Oct 29, 2018	BUY	$5.59 - $10.45 $39 - $73	7 Added 87.5%	15 $0
Q2 2018 Jul 18, 2018	BUY	$7.98 - $12.39 $63 - $99	8 New	8 $0

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.